Lippman Evan

Track

Insider profile

Lippman Evan's trades of Teva Pharmaceutical Industries Ltd's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-19 2026-08-17
PlS Planned sale
89,199 -48.1%
293.25
US$3,523,905 		89,199 -48.1% 293.25 US$3,523,905
2026-08-17 2026-08-17
PrS Proposed sale
5,433
31.89
US$4,674,147 		5,433 31.89 US$4,674,147
2026-05-18 2026-05-14
PlS Planned sale
82,918 +0.6%
434.41
US$197,466 		82,918 +0.6% 434.41 US$197,466
2026-05-18 2026-05-14
PlS Planned sale
35,912 -44.8%
35.58
US$1,277,900 		35,912 -44.8% 35.58 US$1,277,900
2026-05-18 2026-05-14
PlS Planned sale
5,746 -48.5%
35.58
US$204,467 		5,746 -48.5% 35.58 US$204,467
2026-05-18 2026-05-14
PlS Planned sale
5,746 -48.5%
35.58
US$204,467 		5,746 -48.5% 35.58 US$204,467
2026-05-14 2026-05-14
PrS Proposed sale
41,658
35.58
US$1,482,367 		41,658 35.58 US$1,482,367